Imagine spending thousands of dollars on weight-loss medication—only to discover months later that it doesn't work for your ...

There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...

Medicare's new GLP-1 Bridge program offers eligible beneficiaries Wegovy, Zepbound, or Foundayo for $50 a month starting July ...

A $350 genetic test developed by researchers at Mayo Clinic in Rochester, Minn., and subsequently licensed to Phenomic Sciences, seeks to assign risk scores to patients regarding their likelihood of ...

A new GLP-1 medication in oral pill form, elecoglipron, could help to significantly reduce blood sugar levels and body weight ...

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The ...

Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, today announced that patients can now order the MyPhenome® genetic obesity test directly through ...

Dushay is an assistant professor of medicine at Harvard Medical School and an attending endocrinologist at Beth Israel Deaconess Medical Center. It makes my head spin to think about how much GLP-1s ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the science — and culture — of weight loss. Now a growing body of research is raising ...

Share on Pinterest A new generic of the GLP-1 drug Victoza, which is similar to popular medications like Ozempic, Wegovy, Mounjaro, and Zepbound, is now available in the United States.

Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant professor at the University of Colorado Anschutz, she was part of a team studying 13 teens and ...

A weight-loss medication eased Serena Williams’s comeback. Experts can’t agree on whether that counts as doping.